Skip to content
DraconiticResearch
Search Sources API
209,918 studies31 sourcesUpdated 22 min ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,300 studies

  1. Glycoconjugates tune the viscoelastic signature of mammary tumor progression
    Abhishek Sharma, Jane A. Baude, Maya Papez +2
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  2. Testis-Specific MAGEA3/6 Regulate Glycolysis to Promote Metabolic Flexibility and Reveal Therapeutic Vulnerabilities in Pancreatic Cancer Cells
    S. Tozandehjani, V. Jurjevic, D. Stepihar +13
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. METTL1 gene dosage and catalytic activity define a targetable vulnerability in pediatric cancers
    P. Y. Liu, S. He, O. Panasenko +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Oncogenic KRAS-MAPK signaling sustains a CD73 dependent therapeutic vulnerability in pancreatic cancer
    Khadija Turabi, Urvinder Kaur Sardarni, Katherine E. Ankenbauer +10
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  5. A clinically annotated proteomic and histological resource of 1,000 colorectal cancers
    A. Qoku, N. Ullrich, F. Miranda +21
    bioRxivPreprintCC BYFull textOncologybioRxiv
  6. Phenotype-cloud reorganization shapes cancer progression and therapeutic adaptation
    Y. Zhang, J. Ji, M. Gao +17
    bioRxivPreprintCC BYFull textOncologybioRxiv
  7. Efficacy and Safety of Adoptive BK Polyomavirus-Reactive T-Cell Therapy for Active Infection or Disease in Transplant Recipients: A Systematic Review.
    Felix Bratosin, Shiva Charana Kodimala, Alexei Croitor +2
    VirusesPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Cancer-Specific Survival in Octogenarian Breast Cancer Patients: A Competing Risk Analysis of Prognostic Factors.
    Özlem Mermut, Berrin Yalçın, Rıza Umar Gürsu +5
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  9. Frequency of Bloodwork in Patients on Immune Checkpoint Inhibitors.
    John R Goffin, Sze Wah Samuel Chan, Gregory R Pond
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  10. Does the Number of Harvested Sentinel Lymph Nodes Matter in Breast Cancer Patients with Limited Nodal Burden? A Descriptive Cohort Study.
    Geok Hoon Lim, Me Me Win Htein, Fuh Yong Wong +2
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  11. Signs and symptoms preceding cancer diagnosis: a data-driven analysis of primary care records
    D. Newby, E. J. Rowlands, E. Burn +6
    medRxivPreprintCC BYFull textOncologymedRxiv
  12. Statin use and clinical outcomes in patients with head and neck cancer: a systematic review and meta-analysis
    Jiaqi Liu, Hyeonji Cheon, Min Jung Chang +1
    Systematic ReviewsPeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  13. Association of Non‐Cytochrome P450 3A4‐Metabolized Statins Versus Atorvastatin With Major Adverse Cardiovascular Events in Patients With Cancer Receiving Tyrosine Kinase Inhibitors: A Propensity Score–Matched Target Trial Emulation
    Jing‐Huan Liao, Wei‐Cheng Chang, Hong‐Jie Jhou +3
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDOncologyCrossref
  14. Trauma and posttraumatic growth in cancer: validation of the post-traumatic stress disorder checklist for DSM-5 and the posttraumatic growth inventory-short form in patients with breast cancer
    Cláudio Castanheira, Sílvia Almeida, Isabel Manica +6
    Frontiers in PsychiatryPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  15. Artificial intelligence in esophageal cancer: a narrative review from a thoracic surgical perspective
    Dongrong Peng, Wenyi Liu, Baihua Zhang
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  16. ZNF114 as a prognostic biomarker associated with Wnt/EMT and immune-related features in gastric cancer
    Wenzheng Li, Zhengxuan Zhang, Yiyan Li +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  17. Baseline markers and exploratory analysis of post-treatment thyroid autoantibody seroconversion for immune-related thyroid dysfunction in patients with advanced non-small-cell lung cancer treated with ICIs: a prospective single-center cohort study
    Hui Ming, Qun Liang, Wenbing Hu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  18. Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy
    Gulnara Kurmanalina, Vadim Medovchshikov, Setareh Valanik +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  19. JAK-STAT signaling: a key mechanism of immune microenvironment remodeling in breast cancer and novel strategies for targeted therapy
    Junfang Qiao, Tingting Sun, Guoqiang Wang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  20. Predictors of time to feeding-tube independence in locally advanced head and neck cancer
    Saeed Salman, Nancy Heppell, Nadin Dabbah Salman +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  21. Experiences of rehabilitation exercise during the transition from hospital to home among older patients following lung cancer surgery: a qualitative study guided by the social ecological model
    Luga Dong, Yuanyuan Chen, Yi Shang +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  22. Comparative outcomes of adjuvant treatment approaches in resected stage I-III gastric cancer
    Bulent Yildiz, Yasemin Sagdic Karateke, Duygu Bayir Garbioglu +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  23. Design, implementation, and assessment of an independent second-check system for proton and carbon-ion pencil-beam scanning: delivery-aware Monte Carlo and microdosimetric RBE-weighted dose
    Jun Tan, Keith Furutani, Alessio Parisi +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  24. Global and regional gastric cancer burden and age-related survival disparities: complementary analyses of GBD 2021 and SEER data
    Jie Cheng, Ruitong Sun, Yun Gong +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  25. Association between CISD2 expression and clinicopathological features and prognosis in gastric cancer: a systematic review, meta-analysis, and database validation
    Tong Liang, Yaqiong Cui, Hongmei Song
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC